Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic is a clinical research site located in Nashville, Tennessee, United States 37232.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.
Sponsors: Pierre Fabre Medicament, Pharmacyclics LLC..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Nashville
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic has 2 clinical trials on record, with 1 currently active. Their work covers Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders.
Vanderbilt University Medical Center, Henry-Joyce Cancer Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.